Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 915130, 13 pages
http://dx.doi.org/10.1155/2015/915130
Research Article

Effects of Two Fullerene Derivatives on Monocytes and Macrophages

1Department of Life Sciences, University of Trieste, Via L. Giorgieri 5, 34127 Trieste, Italy
2Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via L. Giorgieri 5, 34127 Trieste, Italy
3Callerio Foundation, Institutes of Biological Research, Via A. Fleming 22-31, 34127 Trieste, Italy

Received 27 June 2014; Revised 10 September 2014; Accepted 24 September 2014

Academic Editor: Amitava Mukherjee

Copyright © 2015 Sabrina Pacor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Lehner, X. Wang, S. Marsch, and P. Hunziker, “Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 9, no. 6, pp. 742–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Clemente-Casares and P. Santamaria, “Nanomedicine in autoimmunity,” Immunology Letters, vol. 158, no. 1-2, pp. 167–174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Yang, A. Ebrahimi, J. Li, and Q. Cui, “Fullerene-biomolecule conjugates and their biomedicinal applications,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 77–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Dellinger, Z. Zhou, S. K. Norton, R. Lenk, D. Conrad, and C. L. Kepley, “Uptake and distribution of fullerenes in human mast cells,” Nanomedicine, vol. 6, no. 4, pp. 575–581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Foley, C. Crowley, M. Smaihi et al., “Cellular localisation of a water-soluble fullerene derivative,” Biochemical and Biophysical Research Communications, vol. 294, no. 1, pp. 116–119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. P. A. Martins-Júnior, C. E. Alcântara, R. R. Resende, and A. J. Ferreira, “Carbon nanotubes: directions and perspectives in oral regenerative medicine,” Journal of Dental Research, vol. 92, no. 7, pp. 575–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Shi, H. Zhang, L. Wang et al., “PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor,” Biomaterials, vol. 34, no. 1, pp. 251–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Shi, X. Yu, L. Wang et al., “PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging,” Biomaterials, vol. 34, no. 37, pp. 9666–9677, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Lucafò, S. Pacor, C. Fabbro et al., “Study of a potential drug delivery system based on carbon nanoparticles: effects of fullerene derivatives in MCF7 mammary carcinoma cells,” Journal of Nanoparticle Research, vol. 14, no. 4, article 830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lucafò, M. Gerdol, A. Pallavicini et al., “Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq,” Toxicology, vol. 314, no. 1, pp. 183–192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Bosi, T. da Ros, G. Spalluto, and M. Prato, “Fullerene derivatives: an attractive tool for biological applications,” European Journal of Medicinal Chemistry, vol. 38, no. 11-12, pp. 913–923, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Bennett and S. N. Breit, “Variables in the isolation and culture of human monocytes that are of particular relevance to studies of HIV,” Journal of Leukocyte Biology, vol. 56, no. 3, pp. 236–240, 1994. View at Google Scholar · View at Scopus
  13. A. Cossarizza and S. Salvioli, “Flow cytometric analysis of mitochondrial membrane potential using JC-1,” Current Protocols in Cytometry, vol. 9, no. 14, 2001. View at Google Scholar
  14. N. A. Monteiro-Riviere, A. O. Inman, and L. W. Zhang, “Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line,” Toxicology and Applied Pharmacology, vol. 234, no. 2, pp. 222–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kroll, M. H. Pillukat, D. Hahn, and J. Schnekenburger, “Current in vitro methods in nanoparticle risk assessment: limitations and challenges,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 2, pp. 370–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Bryant and K. A. Fitzgerald, “Molecular mechanisms involved in inflammasome activation,” Trends in Cell Biology, vol. 19, no. 9, pp. 455–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Dostert, V. Pétrilli, R. van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, “Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica,” Science, vol. 320, no. 5876, pp. 674–677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Hillegass, J. M. Miller, M. B. MacPherson et al., “Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells,” Particle and Fibre Toxicology, vol. 10, article 39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Trautmann, “Extracellular ATP in the immune system: more than just a “danger signal”,” Science Signaling, vol. 2, no. 56, article pe6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. P. Green and W. A. Phillips, “Activation of the macrophage respiratory burst by phorbol myristate acetate: evidence for both tyrosine-kinase-dependent and -independent pathways,” Biochimica et Biophysica Acta, vol. 1222, no. 2, pp. 241–248, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Pelegrin and A. Surprenant, “Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1Β release through pyrophosphates,” The EMBO Journal, vol. 28, no. 14, pp. 2114–2127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. V. A. Chistyakov, Y. O. Smirnova, E. V. Prazdnova, and A. V. Soldatov, “Possible mechanisms of fullerene C60 antioxidant action,” BioMed Research International, vol. 2013, Article ID 821498, 4 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Markovic and V. Trajkovic, “Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60),” Biomaterials, vol. 29, no. 26, pp. 3561–3573, 2008. View at Publisher · View at Google Scholar
  25. U.-S. Jeng, T.-L. Lin, T.-S. Chang et al., “Comparison of the aggregation behavior of water-soluble hexa(sulfobutyl)fullerenes and polyhydroxylated fullerenes for their free-radical scavenging activity,” Progress in Colloid and Polymer Science, vol. 118, pp. 232–237, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. K. K. Chin, S. C. Chuang, B. Hernandez, M. Selke, C. S. Foote, and M. A. Garcia-Garibay, “Photophysical properties of a 1,2,3,4,5,6-hexasubstituted fullerene derivative,” The Journal of Physical Chemistry A, vol. 110, no. 51, pp. 13662–13666, 2006. View at Google Scholar